Clinical trial Recruiting at 1 site Observational Ages 18 to 110

Management of severe limb ischaemia and its outcomes

Official title: Leg Ischaemia Management Collaboration

Run by University of Leicester · NCT04027244 · Data updated 2026-11-12

This study looks at patients with severe limb ischaemia to see how often they need major amputations within a year and how factors like frailty and heart health affect their outcomes.

More Cognitive Impairment trials

Quick facts

Study typeObservational
Ages18 Years to 110 Years
SexAll
Enrollment420 (estimated)
SponsorUniversity of Leicester
Academic / other
Locations1 site (Leicester, Leicestershire)
StatusRecruiting
StartedMay 10, 2019
Main results expectedMay 9, 2022
Study endsMay 9, 2031
Registry record updatedNovember 4, 2020
Trial IDNCT04027244 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients presenting with severe limb ischaemia due to peripheral arterial occlusive disease.

Probably not a fit

Patients whose severe limb ischaemia is not caused by peripheral arterial occlusive disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients presenting with severe limb ischaemia (SLI) at the Leicester Vascular Institute. It aims to determine the rate of major lower limb amputations within 12 months of presentation and assess various outcomes related to frailty, cognitive impairment, and cardiac health. The study will compare results with a historical cohort and establish a biobank for future biomarker analysis. By investigating the interplay of these factors, the study seeks to improve risk stratification and management of patients with SLI.

Why it matters

Potential benefit: If successful, this study could lead to improved management strategies that reduce the need for amputations and enhance patient quality of life.

How similar studies have gone: While studies on limb ischaemia exist, this specific approach focusing on a rapid-access limb salvage clinic and comprehensive assessments is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
PRIMARY COHORT

Inclusion Criteria:

* All patients presenting to the Leicester Vascular Institute with SLI

Exclusion Criteria:

* SLI not caused by PAOD
* Patients undergoing intervention during their index presentation prior to recruitment
* Patients lacking capacity to consent with no accompanying next of kin, relative, partner or friend who can act as a personal consulted
* Patients who cannot read, write or understand English
* Any significant disease or disorder which may either put the patient at risk because of participation in the study, or may influence the results of the study or the patient's ability to participate in the study

FRAILTY \& COGNITIVE ADDITIONAL ASSESSMENTS

Inclusion criteria:

* Patients recruited to the primary cohort in whom a decision has been made to undergo an intervention for SLI
* Patients aged ≥65 years

Exclusion criteria:

* Nil additional

CARDIAC MRI ADDITIONAL ASSESSMENTS

Inclusion criteria:

* Patients recruited to the primary cohort in whom a decision has been made to undergo an intervention

Exclusion criteria:

* Absolute contraindications to cardiac MRI (Pregnancy, Non-MR safe permanent pacemaker, implanted cardiac defibrillator, intra-auricular implant or intra-cranial clips, severe claustrophobia, unstable angina)
* Contraindication to gadolinium contrast agent (Known adverse reaction, chronic renal failure (eGFR \<30mL/min/1.73m\^2))
* Patients lacking capacity to consent for cardiac MRI

BIOMARKERS ADDITIONAL ASSESSMENTS

* Patients recruited to the primary cohort in whom a decision has been made to undergo an intervention

Exclusion criteria:

* Nil additional

Where it's running

  • Glenfield Hospital Leicester
    Leicester, Leicestershire, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.